Market Overview:
The global atherectomy devices market size reached US$ 877 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,202 Million by 2027, exhibiting a growth rate (CAGR) of 5.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Atherectomy devices refer to various minimally invasive (MI) instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaving, sanding and vaporizing plaque, calcifying lesions and excessive cellular material. Some of the commonly used atherectomy devices include direction, orbital, photo-ablative, rotational and support atherectomy devices. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.
The increasing prevalence of peripheral artery disease (PAD), atherosclerosis, diabetes and obesity, along with the rising geriatric population across the globe, represent as the key factors driving the growth of the market. Furthermore, the growing preference for MI atherectomy surgical procedures among both patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons (DCB), are acting as other growth-inducing factors. DCBs are used in place of permanent implants with directional atherectomy and anti-restenosis therapy (DAART) to deliver anti-proliferative drugs and treat lesions with severe calcifications. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global atherectomy devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
- Directional Atherectomy Devices
- Orbital Atherectomy Devices
- Photo-Ablative Atherectomy Devices
- Rotational Atherectomy Devices
- Support Devices
Breakup by Application:
- Peripheral Vascular
- Cardiovascular
- Neurovascular
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Research Laboratories and Academic Institutes
Breakup by Region:
- North America
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company) and Terumo Corporation.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Million |
Segment Coverage |
Product, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company) and Terumo Corporation |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |